Aroa Biosurgery Limited (ASX:ARX)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	221	147	191	360	265	361
Market Cap Growth	-23.27%	-23.27%	-46.97%	35.74%	-26.45%	-
Enterprise Value	207	133	165	321	207	339
Last Close Price	0.64	0.42	0.56	1.05	0.78	1.20
Forward PE	72.37	37.72	-	-	-	-
PS Ratio	2.87	1.91	3.02	6.09	7.22	17.59
PB Ratio	2.61	1.73	2.19	3.79	2.85	6.72
P/TBV Ratio	3.10	2.06	2.63	4.51	3.44	9.72
EV/Sales Ratio	2.68	1.73	2.60	5.43	5.65	16.50
EV/EBITDA Ratio	167.73	573.12	-	-	-	-
Debt / Equity Ratio	0.07	0.07	0.08	0.07	0.06	0.28
Debt / EBITDA Ratio	4.74	4.74	-	9.83	-	-
Asset Turnover	0.77	0.77	0.61	0.55	0.41	0.36
Inventory Turnover	1.48	1.48	1.56	2.24	2.47	1.79
Quick Ratio	5.58	5.58	6.21	9.06	11.11	2.89
Current Ratio	6.62	6.62	7.26	9.88	11.90	3.19
Return on Equity (ROE)	-4.06%	-4.06%	-10.80%	-0.39%	-10.55%	-58.13%
Return on Assets (ROA)	-1.66%	-1.66%	-5.86%	-1.70%	-4.97%	-9.93%
Return on Capital (ROIC)	-1.81%	-1.81%	-6.31%	-1.81%	-5.28%	-11.54%
Earnings Yield	-1.57%	-2.36%	-5.10%	-0.10%	-2.93%	-4.89%
FCF Yield	-2.01%	-3.02%	-5.23%	-2.54%	-5.57%	-1.60%
Buyback Yield / Dilution	-0.31%	-0.31%	-0.27%	-0.22%	-13.90%	-10620.95%

Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.